Abstract P3-09-12: Peripheral T cell clonality and exhaustion as novel biomarkers for anti-PD-1 (pembrolizumab) maintenance therapy in patients with metastatic inflammatory breast cancer (mIBC) and non-IBC triple negative breast cancer (mTNBC)

Name: Work Video:
Duration: 3 min 30 s
Hui Gao; Kumiko Kida; Evan N. Cohen; Angela Alexander; Bora Lim; Charla A. Parker; Sanda Tin; Vicente Valero; Debu Tripathy; Alexandre Reuben; Naoto T. Ueno; James M. Reuben
{'id': 'https://openalex.org/W3013885934', 'doi': 'https://doi.org/10.1158/1538-7445.sabcs19-p3-09-12', 'title': 'Abstract P3-09-12: Peripheral T cell clonality and exhaustion as novel biomarkers for anti-PD-1 (pembrolizumab) maintenance therapy in patients with metastatic inflammatory breast cancer (mIBC) and non-IBC triple negative breast cancer (mTNBC)', 'display_name': 'Abstract P3-09-12: Peripheral T cell clonality and exhaustion as novel biomarkers for anti-PD-1 (pembrolizumab) maintenance therapy in patients with metastatic inflammatory breast cancer (mIBC) and non-IBC triple negative breast cancer (mTNBC)', 'publication_year': 2020, 'publication_date': '2020-02-15', 'ids': {'openalex': 'https://openalex.org/W3013885934', 'doi': 'https://doi.org/10.1158/1538-7445.sabcs19-p3-09-12', 'mag': '3013885934'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.sabcs19-p3-09-12', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5100623130', 'display_name': 'Hui Gao', 'orcid': 'https://orcid.org/0000-0002-5009-9999'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Hui Gao', 'raw_affiliation_strings': ['UT MD Anderson Cancer Center, Houston, TX'], 'affiliations': [{'raw_affiliation_string': 'UT MD Anderson Cancer Center, Houston, TX', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5025607663', 'display_name': 'Kumiko Kida', 'orcid': 'https://orcid.org/0000-0002-0946-5053'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Kumiko Kida', 'raw_affiliation_strings': ['UT MD Anderson Cancer Center, Houston, TX'], 'affiliations': [{'raw_affiliation_string': 'UT MD Anderson Cancer Center, Houston, TX', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5069614323', 'display_name': 'Evan N. Cohen', 'orcid': 'https://orcid.org/0000-0003-4192-9644'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Evan N Cohen', 'raw_affiliation_strings': ['UT MD Anderson Cancer Center, Houston, TX'], 'affiliations': [{'raw_affiliation_string': 'UT MD Anderson Cancer Center, Houston, TX', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5070852357', 'display_name': 'Angela Alexander', 'orcid': 'https://orcid.org/0000-0002-6649-7991'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Angela Alexander', 'raw_affiliation_strings': ['UT MD Anderson Cancer Center, Houston, TX'], 'affiliations': [{'raw_affiliation_string': 'UT MD Anderson Cancer Center, Houston, TX', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5053893309', 'display_name': 'Bora Lim', 'orcid': 'https://orcid.org/0000-0002-4182-6058'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Bora Lim', 'raw_affiliation_strings': ['UT MD Anderson Cancer Center, Houston, TX'], 'affiliations': [{'raw_affiliation_string': 'UT MD Anderson Cancer Center, Houston, TX', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5102111556', 'display_name': 'Charla A. Parker', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Charla Parker', 'raw_affiliation_strings': ['UT MD Anderson Cancer Center, Houston, TX'], 'affiliations': [{'raw_affiliation_string': 'UT MD Anderson Cancer Center, Houston, TX', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5110016768', 'display_name': 'Sanda Tin', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Sanda Tin', 'raw_affiliation_strings': ['UT MD Anderson Cancer Center, Houston, TX'], 'affiliations': [{'raw_affiliation_string': 'UT MD Anderson Cancer Center, Houston, TX', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5080832682', 'display_name': 'Vicente Valero', 'orcid': 'https://orcid.org/0000-0001-5913-7480'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Vicente Valero', 'raw_affiliation_strings': ['UT MD Anderson Cancer Center, Houston, TX'], 'affiliations': [{'raw_affiliation_string': 'UT MD Anderson Cancer Center, Houston, TX', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5110083321', 'display_name': 'Debu Tripathy', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Debu Tripathy', 'raw_affiliation_strings': ['UT MD Anderson Cancer Center, Houston, TX'], 'affiliations': [{'raw_affiliation_string': 'UT MD Anderson Cancer Center, Houston, TX', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5088889988', 'display_name': 'Alexandre Reuben', 'orcid': 'https://orcid.org/0000-0003-4510-0382'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Alexandre Reuben', 'raw_affiliation_strings': ['UT MD Anderson Cancer Center, Houston, TX'], 'affiliations': [{'raw_affiliation_string': 'UT MD Anderson Cancer Center, Houston, TX', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5088814426', 'display_name': 'Naoto T. Ueno', 'orcid': 'https://orcid.org/0000-0002-0166-7275'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Naoto T Ueno', 'raw_affiliation_strings': ['UT MD Anderson Cancer Center, Houston, TX'], 'affiliations': [{'raw_affiliation_string': 'UT MD Anderson Cancer Center, Houston, TX', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5040423978', 'display_name': 'James M. Reuben', 'orcid': 'https://orcid.org/0000-0001-8972-2103'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'James M Reuben', 'raw_affiliation_strings': ['UT MD Anderson Cancer Center, Houston, TX'], 'affiliations': [{'raw_affiliation_string': 'UT MD Anderson Cancer Center, Houston, TX', 'institution_ids': ['https://openalex.org/I1343551460']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.476, 'has_fulltext': False, 'cited_by_count': 5, 'citation_normalized_percentile': {'value': 0.676803, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 79, 'max': 81}, 'biblio': {'volume': '80', 'issue': '4_Supplement', 'first_page': 'P3', 'last_page': '12'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10158', 'display_name': 'Cancer Immunotherapy and Biomarkers', 'score': 0.9994, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10158', 'display_name': 'Cancer Immunotherapy and Biomarkers', 'score': 0.9994, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12626', 'display_name': 'Cancer, Stress, Anesthesia, and Immune Response', 'score': 0.9916, 'subfield': {'id': 'https://openalex.org/subfields/2738', 'display_name': 'Psychiatry and Mental health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11491', 'display_name': 'CAR-T cell therapy research', 'score': 0.9827, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/triple-negative-breast-cancer', 'display_name': 'Triple-negative breast cancer', 'score': 0.6208048}], 'concepts': [{'id': 'https://openalex.org/C2780057760', 'wikidata': 'https://www.wikidata.org/wiki/Q13896859', 'display_name': 'Pembrolizumab', 'level': 4, 'score': 0.79227376}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.753284}, {'id': 'https://openalex.org/C530470458', 'wikidata': 'https://www.wikidata.org/wiki/Q128581', 'display_name': 'Breast cancer', 'level': 3, 'score': 0.6604774}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.6372389}, {'id': 'https://openalex.org/C2780110267', 'wikidata': 'https://www.wikidata.org/wiki/Q7843332', 'display_name': 'Triple-negative breast cancer', 'level': 4, 'score': 0.6208048}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.5474917}, {'id': 'https://openalex.org/C2775930923', 'wikidata': 'https://www.wikidata.org/wiki/Q12859063', 'display_name': 'Metastatic breast cancer', 'level': 4, 'score': 0.42673263}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.42132068}, {'id': 'https://openalex.org/C203014093', 'wikidata': 'https://www.wikidata.org/wiki/Q101929', 'display_name': 'Immunology', 'level': 1, 'score': 0.3919204}, {'id': 'https://openalex.org/C2777701055', 'wikidata': 'https://www.wikidata.org/wiki/Q1427096', 'display_name': 'Immunotherapy', 'level': 3, 'score': 0.30956447}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.sabcs19-p3-09-12', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'score': 0.44, 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4311332848', 'https://openalex.org/W4310834173', 'https://openalex.org/W4225264283', 'https://openalex.org/W3215044659', 'https://openalex.org/W3164806321', 'https://openalex.org/W3113081998', 'https://openalex.org/W3010740851', 'https://openalex.org/W2982645126', 'https://openalex.org/W2554176272', 'https://openalex.org/W1999292713'], 'abstract_inverted_index': {'Abstract': [0], 'Background:': [1], 'Inflammatory': [2], 'breast': [3, 9, 17, 43, 544, 551], 'cancer': [4, 10, 18, 545, 552], '(IBC)': [5], 'and': [6, 20, 56, 103, 123, 167, 198, 217, 220, 242, 253, 283, 293, 334, 348, 379, 395, 423, 431, 450, 476, 485, 529, 547], 'triple': [7, 549], 'negative': [8, 550], '(TNBC)': [11], 'are': [12, 68], 'more': [13, 339, 386], 'aggressive': [14], 'than': [15, 312, 353], 'other': [16], 'subtypes,': [19], 'up': [21], 'until': [22], 'recently': [23], 'lacked': [24], 'therapy': [25, 51, 92, 146, 180, 538], 'options': [26], 'that': [27, 445, 473], 'maintain': [28, 82], 'acceptable': [29], 'quality': [30], 'of': [31, 42, 64, 73, 100, 164, 184, 189, 231, 325, 454, 478, 557], 'life.': [32], 'While': [33], 'chemotherapy': [34, 157], 'is': [35, 46], 'a': [36, 149, 322, 396, 451], 'treatment': [37, 232], 'option': [38], 'for': [39, 52, 158, 464, 534], 'all': [40], 'subtypes': [41], 'cancer,': [44], 'it': [45], 'used': [47], 'long-term': [48], 'as': [49, 144, 531], 'maintenance': [50, 145, 466, 537], 'metastatic': [53, 117, 159, 542], 'TNBC': [54], '(mTNBC)': [55, 553], 'often': [57], 'produces': [58], 'cumulative': [59], 'toxicity': [60], 'resulting': [61], 'in': [62, 113, 299, 308, 313, 364, 369, 409, 414, 539], 'discontinuation': [63, 72], 'treatment.': [65], 'Moreover,': [66], 'responses': [67, 437], 'rarely': [69], 'durable': [70], 'after': [71, 147], 'chemotherapy.': [74], 'Immune': [75], 'checkpoint': [76, 440, 494], 'blockade': [77], 'has': [78], 'the': [79, 237, 274, 281, 284, 558], 'potential': [80], 'to': [81, 90, 105, 141, 155, 235, 270, 287, 341, 359, 388, 400, 404, 434, 438, 489], 'therapy.': [83, 187, 467], 'To': [84], 'determine': [85], 'factors': [86, 463], 'associated': [87], 'with': [88, 109, 116, 127, 233, 244, 310, 315, 321, 355, 376, 492, 541], 'response': [89, 151], 'anti-PD-1': [91, 535], '(pembrolizumab),': [93], 'we': [94], 'performed': [95, 162], 'minimally': [96], 'invasive': [97], 'blood-based': [98], 'analyses': [99, 163], 'T-cell': [101, 165, 190, 207, 240, 421, 424, 446, 474, 479], 'repertoire': [102, 166, 241], 'phenotype': [104, 168, 243], 'evaluate': [106, 236], 'their': [107], 'association': [108, 238], 'progression-free': [110], 'survival': [111], '(PFS)': [112], '15': [114], 'patients': [115, 126, 248, 275, 309, 314, 354, 375, 540], 'IBC': [118], '(mIBC)': [119, 546], 'or': [120, 130, 152], 'mTNBC.': [121], 'Materials': [122], 'Methods:': [124], 'Fifteen': [125], 'mIBC': [128], '(n=6)': [129], 'mTNBC': [131], '(n=9)': [132], 'were': [133, 223, 226, 338, 385, 460], 'enrolled': [134], 'on': [135, 169, 202], 'an': [136], 'ongoing': [137], 'phase': [138], 'II': [139], 'study': [140], 'receive': [142], 'pembrolizumab': [143, 185, 234, 465], 'achieving': [148], 'clinical': [150], 'stable': [153, 250], 'disease': [154, 251, 257], 'systemic': [156], 'disease.': [160], 'We': [161], 'peripheral': [170], 'blood': [171], 'mononuclear': [172], 'cells': [173, 302, 328, 457], '(PBMC)': [174], 'from': [175], 'samples': [176], 'obtained': [177], 'post': [178], 'induction': [179], 'but': [181], 'before': [182], 'initiation': [183], '(baseline)': [186], 'Expression': [188], 'exhaustion': [191, 330, 383, 425, 480, 530], 'markers': [192, 331, 384, 426, 481], '2B4,': [193], 'CTLA4,': [194], 'BTLA,': [195], 'Lag3,': [196], 'PD-1,': [197], 'Tim3': [199], 'was': [200, 265, 289, 305, 361, 406], 'evaluated': [201], 'PBMC': [203], 'by': [204, 215, 259], 'flow': [205], 'cytometry.': [206], 'receptor': [208], '(TCR)': [209], 'beta': [210], 'chain': [211], 'CDR3': [212], 'DNA': [213], 'sequencing': [214], 'ImmunoSEQ': [216], 'richness': [218], '(diversity)': [219], 'clonality': [221, 378, 422, 475, 528], '(reactivity)': [222], 'evaluated.': [224], 'Patients': [225, 320], 'followed': [227], 'through': [228], '5': [229, 260, 279], 'months': [230, 267, 292, 368, 413], 'between': [239], 'PFS.': [245], 'Results:': [246], 'Seven': [247], 'had': [249, 255], '(SD)': [252], '8': [254], 'progressive': [256], '(PD)': [258], 'months.': [261], 'The': [262], 'median': [263, 351, 398], 'follow-up': [264], '14.2': [266], '(range:': [268], '4.5': [269], '27.7': [271], 'months).': [272], 'Among': [273], 'who': [276], 'progressed': [277], 'within': [278], 'months,': [280, 295], 'earliest': [282], 'latest': [285], 'time': [286, 358, 399, 403], 'progression': [288, 360, 401, 405], 'at': [290, 303, 336, 448], '1.38': [291], '4.82': [294], 'respectively.': [296], 'CTLA4': [297], 'expression': [298], 'CD4+': [300, 326, 381, 455], 'T': [301, 327, 382, 456, 520, 526], 'baseline': [304, 337], 'significantly': [306, 349], 'higher': [307], 'PD': [311, 356], 'SD': [316, 343, 365, 390, 410], '(p': [317], '=': [318, 346, 372, 393, 417], '0.040).': [319], 'low': [323, 380], 'percentage': [324, 453], 'expressing': [329, 458], '(CTLA4,': [332], 'Tim3,': [333], '2B4)': [335], 'likely': [340, 387], 'have': [342, 389, 427], '(chi-square': [344, 391], 'p': [345, 371, 392, 416], '0.041)': [347, 394], 'longer': [350, 397], 'PFS': [352], '(median': [357, 402], 'not': [362, 407], 'reached': [363, 408], 'vs.': [366, 411], '4.1': [367, 412], 'PD,': [370, 415], '0.018).': [373], 'Additionally,': [374], 'high': [377], '0.015).': [418], 'Conclusions:': [419], 'Baseline': [420], 'significant': [428], 'translational': [429], 'relevance': [430], 'can': [432, 482], 'help': [433], 'explain': [435], 'variable': [436], 'immune': [439, 493], 'blockade.': [441], 'Our': [442], 'data': [443, 472], 'suggest': [444], 'reactivity': [447], 'baseline,': [449], 'lower': [452], 'CTLA4/Tim3/2B4': [459], 'favorable': [461], 'prognostic': [462], 'This': [468], 'proof-of-concept': [469], 'provides': [470], 'compelling': [471], 'phenotyping': [477], 'be': [483, 487], 'useful': [484], 'should': [486], 'applied': [488], 'future': [490], 'trials': [491], 'inhibitors.': [495], 'Citation': [496], 'Format:': [497], 'Hui': [498], 'Gao,': [499], 'Kumiko': [500], 'Kida,': [501], 'Evan': [502], 'N': [503], 'Cohen,': [504], 'Angela': [505], 'Alexander,': [506], 'Bora': [507], 'Lim,': [508], 'Charla': [509], 'Parker,': [510], 'Sanda': [511], 'Tin,': [512], 'Vicente': [513], 'Valero,': [514], 'Debu': [515], 'Tripathy,': [516], 'Alexandre': [517], 'Reuben,': [518], 'Naoto': [519], 'Ueno,': [521], 'James': [522], 'M': [523], 'Reuben.': [524], 'Peripheral': [525], 'cell': [527], 'novel': [532], 'biomarkers': [533], '(pembrolizumab)': [536], 'inflammatory': [543], 'non-IBC': [548], '[abstract].': [554], 'In:': [555], 'Proceedings': [556], '2019': [559, 565], 'San': [560, 568], 'Antonio': [561], 'Breast': [562], 'Cancer': [563, 574], 'Symposium;': [564], 'Dec': [566], '10-14;': [567], 'Antonio,': [569], 'TX.': [570], 'Philadelphia': [571], '(PA):': [572], 'AACR;': [573], 'Res': [575], '2020;80(4': [576], 'Suppl):Abstract': [577], 'nr': [578], 'P3-09-12.': [579]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W3013885934', 'counts_by_year': [{'year': 2023, 'cited_by_count': 3}, {'year': 2022, 'cited_by_count': 1}, {'year': 2021, 'cited_by_count': 1}], 'updated_date': '2024-12-07T15:18:46.886905', 'created_date': '2020-04-03'}
Publication Information

Basic Information

Access and Citation

AI Researcher Chatbot

Primary Location

Authors

Topics

Keywords

Related Works
